Institut National de la Recherche Scientifique, Centre Armand-Frappier Santé Biotechnologie, Groupe de Recherche en Ingénierie des Peptides et en Pharmacothérapie (GRIPP), Université du Québec, Laval, Québec H7V 5B7, Canada
Auto-generated profile, based on publicly available information
Juliana C Cunico Dallagnol
Institut National de la Recherche Scientifique, Centre Armand-Frappier Santé Biotechnologie, Groupe de Recherche en Ingénierie des Peptides et en Pharmacothérapie (GRIPP), Université du Québec, Laval, Québec H7V 5B7, Canada
Contulakins are a subclass of conopeptides derived from cone snail venom, known for their analgesic properties mediated through activation of neurotensin receptors NTS1 and NTS2. Among them, contulakin-G, isolated from Conus geographus, exhibits a favorable pharmacokinetic profile, including a 24-hour plasma half-life, and produces potent opioid-independent antinociceptive effects. To facilitate synthesis while preserving analgesic efficacy, we investigated the structure-activity relationships of contulakin-G, focusing on modifications to the glycosylated Thr10 residue. In the first series, Thr10 was substituted by natural and non-natural amino acids encompassing diverse physiochemical and steric properties. Most substitutions had minimal impact on receptor affinity, though some increased the NTS2/NTS1 selectivity ratio. Of these, only the Tyr10 analog retained antinociceptive efficacy comparable to native contulakin-G. Building on tyrosine's hydrophobicity, a second series introduced non-natural hydrophobic residues at position 10, including Gln-cycloheptyl, Gln-biphenylmethyl, and Gln-dimethyladamantyl, along with a non-glycosylated form. In both tonic and postoperative pain models, the non-glycosylated and Gln-cycloheptyl analogs demonstrated potent analgesic activity, comparable to contulakin-G and reversed mechanical allodynia in a neuropathic pain model. In contrast, a third series involving N-terminal truncations led to reduced plasma half-life and loss of antinociceptive efficacy, underscoring the importance of the N-terminal region. Molecular modeling further revealed that full-length analogs engage a broader NTS2 binding interface than truncated derivatives. These findings support the development of synthetically accessible contulakin-G analogs as promising non-opioid analgesics.
Evidence across G protein-coupled receptor systems indicates that subtle modifications in three-dimensional ligand architecture can profoundly influence receptor signaling. However, the contribution of conformational constraints at the Trp4 position, of the urotensin II-related peptide (URP), to signal transduction and functional selectivity at the human urotensin II receptor (hUTR) remains poorly understood. Here, we revisited a series of previously described conformationally constrained URP analogs and comprehensively characterized their signaling profiles at the hUTR. Signaling outputs of [D-Tiq4]URP, [L-Tpi4]URP, [D-Aia4]URP, and [D-Phg4]URP were evaluated using bioluminescence resonance energy transfer (BRET)-based assays to monitor Gaq, Ga12, DAG production, PKN1 activation and β-arrestin1/2 recruitment. Ligand bias was quantified using the operational model of partial agonism Log(t/KA). Despite displaying nanomolar binding affinities (ranging from 9 to 60 nM) and reaching maximal contractile responses comparable or superior to the reference URP, the analogs exhibited markedly distinct signaling signatures. [L-Tpi4]URP showed partial agonism across all pathways except Gaq, despite binding affinity comparable to URP. [D-Aia4]URP produced a more pronounced reduction in signaling outputs compared to URP, with a pronounced reduction in potency for Gaq activation. In contrast, the smaller analogs [D-Phg4]URP and [D-Tiq4]URP evoked potent Gaq activation. Notably, [D-Tiq4]URP was the only analog that preserved β-arrestin recruitment at levels comparable to URP. Collectively, these findings demonstrate that conformational restriction at Trp4 can differentially modulate hUTR signaling while preserving receptor recognition, highlighting this position as a critical structural determinant of functional selectivity and ligand-directed signaling.